Conditions4 min read
GLP-1 Drugs and Fatty Liver (MASH): What Patients Need to Know
Fatty liver disease is one of the most common chronic liver conditions in the world, yet it rarely gets the attention it deserves. The approval of Wegovy for MASH in August 2025 ma...
W
WeightEasy Editorial Team